Cardiac monitoring

Holter Monitors Market - Global Outlook and Forecast 2020-2025: Key Vendors are GE Healthcare, Koninklijke Philips, iRhythm Technologies, Hillrom & BioTelemetry - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 12, 2020

The holter monitors market by revenue is expected to grow at a CAGR of over 8% during the period 2020-2025.

Key Points: 
  • The holter monitors market by revenue is expected to grow at a CAGR of over 8% during the period 2020-2025.
  • The global Holter monitors market is one of the fastest-growing segments of the ambulatory cardiac monitoring devices market.
  • GE Healthcare, Koninklijke Philips, iRhyhm Technologies, Hillrom, and BioTelemetry are the key vendors in the market.
  • The following factors are likely to contribute to the growth of the holter monitors market during the forecast period:

The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6%

Retrieved on: 
Tuesday, November 10, 2020

NEW YORK, Nov. 10, 2020 /PRNewswire/ -- The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period.

Key Points: 
  • NEW YORK, Nov. 10, 2020 /PRNewswire/ -- The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period.
  • In terms of products, blood glucose monitoring systems segment to register significant growth during the forecast period.
  • Based on the product, the patient monitoring devices market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices.Significant growth of the segment is attributed to the ongoing product approval of continuous glucose monitoring systems, advantages offered by continuous glucose monitoring systemsover self-monitoring blood glucose systems, and technological advancements in the market.
  • Apart from this, the rising number of hospitals and ambulatory surgical centers in the APAC region is expected to propel the market for patient monitoring devices.

Patient Monitoring Devices Market worth $55.1 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, November 3, 2020

Based on the product, the patient monitoring device market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices.

Key Points: 
  • Based on the product, the patient monitoring device market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices.
  • Among the cardiac monitoring devices products, the ECG devices segment held a major share of the market in 2019.
  • Increasing number of clinical trials validating patient monitoring devices and a growing number of approvals for patient monitoring.
  • Customers in North America are moving towards homecare patient monitoring, which requires non-invasive patient monitoring devices.

Patient Monitoring Devices Market worth $55.1 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, November 3, 2020

Based on the product, the patient monitoring device market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices.

Key Points: 
  • Based on the product, the patient monitoring device market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices.
  • Among the cardiac monitoring devices products, the ECG devices segment held a major share of the market in 2019.
  • Increasing number of clinical trials validating patient monitoring devices and a growing number of approvals for patient monitoring.
  • Customers in North America are moving towards homecare patient monitoring, which requires non-invasive patient monitoring devices.

Cardiac Insight Increases Access to Lifesaving Wearable ECG AFib Detection Technology with Record Sales

Retrieved on: 
Tuesday, October 20, 2020

Cardiac Insight reports 86 percent growth compared to the same period through Q32019, despite challenges presented amid the COVID-19 pandemic and limited access to healthcare providers.

Key Points: 
  • Cardiac Insight reports 86 percent growth compared to the same period through Q32019, despite challenges presented amid the COVID-19 pandemic and limited access to healthcare providers.
  • This achievement constitutes a record sales quarter, including new customer acquisition and strong reorder rates from the companys customer base.
  • Cardiac Insight CEO Brad Harlow sees additional growth opportunity in 2021 as favorable reimbursements for long-term ECG monitoring go into effect nationwide.
  • Cardiac Insight, a privately held ECG technology innovator, provides the only all-inclusive seven-day ambulatory ECG system that comes complete with in-office rapid automated analysis and reporting, eliminating the need for outsourced ECG services.

Spring Hills Launches End-to-End Cardiac Program to Help Patients Transition from Hospital to Home

Retrieved on: 
Thursday, October 15, 2020

Safely transitioning patients from the hospital to home is one of the greatest challenges in health care today, says Alex Markowits, Founder and President/CEO of Spring Hills.

Key Points: 
  • Safely transitioning patients from the hospital to home is one of the greatest challenges in health care today, says Alex Markowits, Founder and President/CEO of Spring Hills.
  • So, Spring Hills decided to create a better, more cohesive model, beginning with cardiac care.
  • Spring Hills is the first program in New Jersey to use non-invasive hemodynamic technology for cardiac monitoring in a post-acute setting.
  • Spring Hills Population Health, fully integrated into all medical care teams, establishes relationships with the patient and family at the hospital to facilitate a smooth transition to the Spring Hills cardiac unit.

$26.8 Billion Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Global Forecast to 2025 with Abbott Labs, Medtronic and Boston Scientific Dominating - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 14, 2020

The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is Projected to Reach USD 26.8 Billion by 2025 from USD 22.1 Billion in 2020, at a CAGR of 4.0% from 2020 to 2025.

Key Points: 
  • The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is Projected to Reach USD 26.8 Billion by 2025 from USD 22.1 Billion in 2020, at a CAGR of 4.0% from 2020 to 2025.
  • By end-user, the cardiac monitoring & cardiac rhythm management devices market is segmented into hospitals; clinics, cardiac centers, and ambulatory surgery centers (ASCs); and other end users.
  • Hospitals accounted for the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2019.
  • In 2019, North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market.

Growing Adoption of ECG Monitoring in Reducing Burden of Cardiovascular Diseases to Spur New Wave of Technological Advancement in ECG Devices Market: TMR

Retrieved on: 
Monday, October 12, 2020

Medical device manufacturers in ECG devices market are leaning on improving the workflow of resting ECG devices, thereby boosting the uptake in clinical and hospitals settings.

Key Points: 
  • Medical device manufacturers in ECG devices market are leaning on improving the workflow of resting ECG devices, thereby boosting the uptake in clinical and hospitals settings.
  • The epidemiology of CVD paints a favorable scenario for substantial revenue potential in the ECG devices market.
  • The need for continuous heart rate monitoring in patients with heart attack, strokes, and arrhythmias has boosted the use of ECG devices.
  • Focus of governments in developing and developed regions on reducing the health burden of CVDs has fuelled the demand for ECG monitoring, thereby boosting the ECG devices market.

Growing Adoption of ECG Monitoring in Reducing Burden of Cardiovascular Diseases to Spur New Wave of Technological Advancement in ECG Devices Market: TMR

Retrieved on: 
Monday, October 12, 2020

Medical device manufacturers in ECG devices market are leaning on improving the workflow of resting ECG devices, thereby boosting the uptake in clinical and hospitals settings.

Key Points: 
  • Medical device manufacturers in ECG devices market are leaning on improving the workflow of resting ECG devices, thereby boosting the uptake in clinical and hospitals settings.
  • The epidemiology of CVD paints a favorable scenario for substantial revenue potential in the ECG devices market.
  • The need for continuous heart rate monitoring in patients with heart attack, strokes, and arrhythmias has boosted the use of ECG devices.
  • Focus of governments in developing and developed regions on reducing the health burden of CVDs has fuelled the demand for ECG monitoring, thereby boosting the ECG devices market.

Biotricity Accelerates Shift to Remote Monitoring with Bioflux® Direct Program

Retrieved on: 
Tuesday, September 29, 2020

REDWOOD CITY, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux Direct Program.

Key Points: 
  • REDWOOD CITY, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux Direct Program.
  • Benefits of the Bioflux Direct Program include:
    Biotricitys unveiling of the Bioflux Direct Program comes ahead of the upcoming launch of the companys proprietary Biocare Telemed platform, a comprehensive virtual clinic designed to help clinicians provide telehealth visits to patients from the safety of their homes.
  • Bioflux is a patient-friendly remote cardiac monitoring system technologically engineered to assist diagnosis of heart conditions and enhance patient outcomes.
  • Merging seamlessly with physicians existing platforms and workflows, Bioflux is the obvious clinical-grade solution for remote cardiac monitoring to help physicians diagnose and deliver potentially life-saving interventions.